This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
ARTICLES
HLA-DRB1 and multiple sclerosis in Malta
The authors demonstrate that the DRB1*11 allele reduces the risk of developing multiple sclerosis. This study expands our growing understanding of the complex relationship between the major histocompatibility complex and susceptibility to multiple sclerosis but does not explain the low MS prevalence in Malta compared with nearby Sicily.
See p. 101; Editorial, p. 97
Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis
The authors found that factor X11 C46T gene polymorphism is a common and strong risk factor for cerebral venous thrombosis, comparable to established factors …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy
New treatment alternatives for Duchenne and Becker muscular dystrophy
Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies